This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Alison Dennis
Partner at Taylor Wessing


Alison Dennis is Taylor Wessing's International Co-Head of Life Sciences and Healthcare and practices in both the UK and the Republic of Ireland. In a career of 30 years, Alison has helped hundreds of life sciences companies manage the range of legal challenges involved in commercialising medicinal products and medical devices. She combines an encyclopaedic knowledge of the EU and UK life sciences regulatory environment with an analytical understanding of strategy and business in the life sciences sector.

Alison provides sophisticated advice on regulation, compliance and commercialisation, as well as intellectual property transactions. Alison enjoys the challenge of persuading regulators and notified bodies to reconsider and ultimately overturn their decisions, allowing her clients to commercialise their products, and has been successful on every occasion.

Alison supports clients on the regulatory aspects of outright acquisitions and licences, as well as in due diligence for sizeable corporate transactions and listings. She also helps clients navigate the nuances of structuring and negotiating arrangements with various commercial and health care partners, including for multi-site clinical trials, all within the complex framework of EU regulations, national laws and industry and deontological codes.

Her clients praise the pragmatism and commercial awareness she brings to every legal challenge and transaction, as well as her bright and personable working style.

Agenda Sessions

  • TRI DIALOGUE Guidance and Risks for Decentralised Clinical Trials